Similar results were obtained in another study that compared 40 biopsies of prostate cancer patients with 40 biopsies of benign prostatic hyperplasia and assessed a sharp increase in CD59 expression and colocalization with PTX3 [53]. The gene discussed is PTX3; the disease is benign prostatic hyperplasia.